135 related articles for article (PubMed ID: 36227664)
1. Expression of CD123 Related Long Non-coding RNA in Acute Myeloid Leukemia Bone Marrow Mononuclear Cells and Its Clinical Significance.
Feng Y; Su B; Xu Y; He Y; He R; Ge F
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):140-147. PubMed ID: 36227664
[TBL] [Abstract][Full Text] [Related]
2. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patients.
Aref S; Azmy E; El Ghannam D; Haroun M; Ibrahim L; Sabry M
Cancer Biomark; 2020; 29(1):9-16. PubMed ID: 32417762
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
[TBL] [Abstract][Full Text] [Related]
5. Microarray profiling of bone marrow long non-coding RNA expression in Chinese pediatric acute myeloid leukemia patients.
Cao L; Xiao PF; Tao YF; Hu SY; Lu J; Zhao WL; Li ZH; Wang NN; Wang J; Feng X; Chai YH; Pan J; Gu GX
Oncol Rep; 2016 Feb; 35(2):757-70. PubMed ID: 26573779
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk.
Wang Y
Cancer Biomark; 2019; 26(1):93-108. PubMed ID: 31356197
[TBL] [Abstract][Full Text] [Related]
7. A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemia.
Xu S; Zhang M; Fang X; Meng J; Xing H; Yan D; Liu J; Yang Y; Wen T; Zhang W; Wang J; Wang C; Xu H
J Hematol Oncol; 2021 Nov; 14(1):193. PubMed ID: 34774070
[TBL] [Abstract][Full Text] [Related]
8. Revealing key lncRNAs in cytogenetically normal acute myeloid leukemia by reconstruction of the lncRNA-miRNA-mRNA network.
Sun T; Dong L; Guo Y; Zhao H; Wang M
Sci Rep; 2022 Mar; 12(1):4973. PubMed ID: 35322118
[TBL] [Abstract][Full Text] [Related]
9. CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations.
Rollins-Raval M; Pillai R; Warita K; Mitsuhashi-Warita T; Mehta R; Boyiadzis M; Djokic M; Kant JA; Roth CG
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):212-7. PubMed ID: 22914610
[TBL] [Abstract][Full Text] [Related]
10. [The study of expression and prognostic value of CD123 in acute myeloid leukemia bone marrow blasts].
Yue WQ; Tang GS; Liu M; Cheng H; Ding J; Wang T; Wang JM; Hu XX; Zhang WP; Chen L; Yang JM
Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):876-882. PubMed ID: 29166741
[No Abstract] [Full Text] [Related]
11. LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A.
Zhou W; Xu S; Deng T; Zhou R; Wang C
Hum Cell; 2022 Jan; 35(1):360-378. PubMed ID: 34694569
[TBL] [Abstract][Full Text] [Related]
12. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].
Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374
[No Abstract] [Full Text] [Related]
13. [Prognostic Value of CD123 in Acute Myeloid Leukemia Patients with Intermediate Risk in Normal Karyotype].
Zhang Y; Liu RY; Wang SJ; Wang C; Zhang QT; He C; Xie XS; Wan DM; Jiang ZX; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1880-1884. PubMed ID: 33283714
[TBL] [Abstract][Full Text] [Related]
14. CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
Lamble AJ; Eidenschink Brodersen L; Alonzo TA; Wang J; Pardo L; Sung L; Cooper TM; Kolb EA; Aplenc R; Tasian SK; Loken MR; Meshinchi S
J Clin Oncol; 2022 Jan; 40(3):252-261. PubMed ID: 34855461
[TBL] [Abstract][Full Text] [Related]
15. CD123-targeted therapy in acute myeloid leukemia.
Espinoza-Gutarra MR; Green SD; Zeidner JF; Konig H
Expert Rev Hematol; 2021 Jun; 14(6):561-576. PubMed ID: 34043467
[TBL] [Abstract][Full Text] [Related]
16. Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131- phenotype of the leukemia stem cell population.
Leyton JV; Hu M; Gao C; Turner PV; Dick JE; Minden M; Reilly RM
J Nucl Med; 2011 Sep; 52(9):1465-73. PubMed ID: 21816968
[TBL] [Abstract][Full Text] [Related]
17. CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.
Bonifant CL; Szoor A; Torres D; Joseph N; Velasquez MP; Iwahori K; Gaikwad A; Nguyen P; Arber C; Song XT; Redell M; Gottschalk S
Mol Ther; 2016 Sep; 24(9):1615-26. PubMed ID: 27401038
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2'-5'-oligoadenylate synthetase 2 axis in acute myeloid leukemia.
Zhou H; Jia X; Yang F; Shi P
Bioengineered; 2021 Dec; 12(1):6403-6417. PubMed ID: 34516354
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia.
Kandeel EZ; Madney Y; Eldin DN; Shafik NF
Exp Mol Pathol; 2021 Feb; 118():104597. PubMed ID: 33358743
[TBL] [Abstract][Full Text] [Related]
20. [Expression and Clinical Significance of Leukemia Stem Cell Antigen in Acute Myeloid Leukemia].
Yao DD; Han BQ; Han YF; Zhang YQ; Jin YL; Dai HB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1583-1588. PubMed ID: 30501688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]